Evolving Landscape of Glioma: A Focus on IDH-Mutant Gliomas
October 18th 2024Vinay K. Puduvalli, MD, explores recent advances in glioma classification and treatment, discussing the impact of new WHO guidelines, molecular markers, clinical trials, and emerging therapies like IDH inhibitors on patient care strategies, while identifying persisting challenges and future research priorities in neuro-oncology.
Treatment of Multiple Myeloma: Best Practices from Levine Cancer Institute and Satellites
June 26th 2023Expert panelists from the Levine Cancer Institute and satellite clinics review recent updates in the treatment of multiple myeloma and reflect on how they apply evidence to their clinical practice.
Treatment of Multiple Myeloma: Best Practices from Ochsner Health and Satellites
June 9th 2023Expert physicians from Ochsner Health reflect on how they apply evidence into clinical practice and work between the main campus and satellite clinics to improve patient outcomes in the setting of multiple myeloma.
Treatment of Multiple Myeloma: Best Practices from The MD Anderson Cancer Center and Satellites
May 11th 2023A panel of expert physicians from satellite clinics of MD Anderson review recent updates in the treatment of multiple myeloma and discuss how emerging evidence is applied to their clinical practice.